Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 35,500 ABOS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 35,500 | n/a |
| Jun 3, 2026 | Shattuck Labs, Inc. (STTK) | Grant/Award | 81,000 | n/a |
| Nov 10, 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 50,000 | n/a |
| Jul 16, 2025 | Shattuck Labs, Inc. (STTK) | Grant/Award | 33,150 | n/a |
| Jul 31, 2024 | Mural Oncology plc (MURA) | Grant/Award | 15,334 | n/a |
| Jun 21, 2024 | Shattuck Labs, Inc. (STTK) | Grant/Award | 27,700 | n/a |
| Jun 11, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 12,500 | n/a |
| Jan 4, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 3,495 | n/a |
| May 31, 2023 | Shattuck Labs, Inc. (STTK) | Grant/Award | 40,258 | n/a |
| Jun 10, 2022 | Shattuck Labs, Inc. (STTK) | Grant/Award | 40,258 | n/a |